posted on 2021-07-12, 09:49authored byThomas Gilbert, Quentin Cordier, Stéphanie Polazzi, Marc Bonnefoy, Eilìs Keeble, Andrew Street, Simon Conroy, Antoine Duclos
Background: The Hospital Frailty Risk Score (HFRS) has made it possible internationally to identify subgroups of patients
with characteristics of frailty from routinely collected hospital data.
Objective: To externally validate the HFRS in France.
Design: A retrospective analysis of the French medical information database.
Setting: 743 hospitals in Metropolitan France.
Subjects: All patients aged 75 years or older hospitalised as an emergency in 2017 (n = 1,042,234).
Methods: The HFRS was calculated for each patient based on the index stay and hospitalisations over the preceding 2 years.
Main outcome measures were 30-day in-patient mortality, length of stay (LOS) >10 days and 30-day readmissions. Mixed
logistic regression models were used to investigate the association between outcomes and HFRS score.
Results: Patients with high HFRS risk were associated with increased risk of mortality and prolonged LOS (adjusted odds
ratio [aOR] = 1.38 [1.35–1.42] and 3.27 [3.22–3.32], c-statistics = 0.676 and 0.684, respectively), while it appeared less
predictive of readmissions (aOR = 1.00 [0.98–1.02], c-statistic = 0.600). Model calibration was excellent. Restricting the
score to data prior to index admission reduced discrimination of HFRS substantially.
Conclusions: HFRS can be used in France to determine risks of 30-day in-patient mortality and prolonged LOS, but not
30-day readmissions. Trial registration: Reference ID on clinicaltrials.gov: ID: NCT03905629.
History
Author affiliation
Department of Health Sciences, University of Leicester